Facebook
X
LinkedIn
ForwardIn this activity, there are standards of care and government mandates documentation of prognostic indicators and staging which are constantly evolving new therapeutic approaches introduced or investigated through clinical trials for cancer.
LINK:
Objectives: Upon completion of this activity, the participant should be able to:
1. Apply NCCN guidelines and other evidence-based standards when developing treatment plans for complex or typical cancer cases.
2. Integrate multidisciplinary input (surgical, medical, radiation oncology, pathology, etc.) to formulate individualized treatment strategies for patients discussed in tumor board sessions.
3. Identify emerging treatment modalities and clinical trial options appropriate for non-standard cancer cases.
4. Demonstrate collaborative decision-making during case discussions to optimize patient outcomes and improve care quality.
5. Evaluate and adjust treatment plans based on patient-specific factors and multidisciplinary recommendations to achieve superior outcomesPLANNER/MODERATOR DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For assistance please contact: Kimberlee Martin at [email protected]